(Q35917381)

11 August 2017

Neurochemical bases of tremor and other disorders of movement (English)

1 reference

11 August 2017

Sourkes TL

1

1 reference

11 August 2017

Poirier LJ

series ordinal

2

1 reference

11 August 2017

language of work or name

English

0 references

publication date

1 January 1966

1 reference

Canadian Medical Association Journal

11 August 2017

1 reference

11 August 2017

94

1 reference

11 August 2017

53-60

1 reference

11 August 2017

2

1 reference

DEMONSTRATION AND MAPPING OUT OF NIGRO-NEOSTRIATAL DOPAMINE NEURONS.

11 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1935214

ADMINISTRATION OF DIHYDROXYPHENYLALANINE TO PARKINSONIAN PATIENTS.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1935214

A CONTROLLED CLINICAL TRIAL OF ALPHA METHYL DOPA IN PARKINSONIAN TREMOR.

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1935214

The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1935214

3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1935214

A method for the combined staining of cells and fibers in the nervous system

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1935214

Function of the primate brachium conjunctivum and related structures

11 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1935214

A CLINICAL AND METABOLIC STUDY OF DOPA (3, 4-DIHYDROXYPHENYLALANINE) AND METHYLDOPA IN HUNTINGTON'S CHOREA.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1935214

INFLUENCE OF THE SUBSTANTIA NIGRA ON THE CATECHOLAMINE CONTENT OF THE STRIATUM

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1935214

INFLUENCE OF LOCUS NIGER ON THE CONCENTRATION OF CATECHOLAMINES IN THE STRIATUM

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1935214

EFFECT OF ALPHA-METHYL DOPA AND RESERPINE IN HUNTINGTON'S CHOREA, PARKINSON'S DISEASE AND OTHER MOVEMENT DISORDERS.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1935214

Normal excretion of homovanillic acid in the urine of patients with Huntington's chorea.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1935214

Experimental and histological study of midbrain dyskinesias.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1935214

Occurrence and distribution of dopamine in brain and other tissues.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1935214

On the presence of 3-hydroxytyramine in brain.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1935214

Intracellular distribution of catecholamines in the brain.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1935214

Catechol compounds in rat tissues and in brains of different animals.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1935214

A concept for a role of serotonin and norepinephrine as chemical mediators in the brain.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1935214

Identification and assay of serotonin in brain.

24 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1935214

Interrelationships between Amphetamine and Harmala Alkaloids

24 September 2018

1 reference

12 December 2020

EXPERIENCES WITH L-DOPA IN THE THERAPY OF PARKINSONISM

1 reference

12 December 2020

[On dopamine (hydroxytyramine) metabolism in the rat brain.]

1 reference

12 December 2020

Determination of catecholamines and catecholamino acids by differential spectrophotofluorimetry

1 reference

12 December 2020

[Noradrenalin loss from the isolated rabbit heart following sympathetic nerve irritation and its pharmacological alteration.]

1 reference

12 December 2020

[The L-dihydroxyphenylalanine (L-DOPA) effect in Parkinson's syndrome in man: On the pathogenesis and treatment of Parkinson akinesis]

1 reference

12 December 2020

ADDITIONAL EXPERIMENTAL STUDIES ON L-DOPA IN PARKINSON'S SYNDROME AND RESERPINE PARKINSONISM

1 reference

12 December 2020

Modification of the Marchi technic

1 reference

12 December 2020

[Serpasil treatment of extrapyramidal hyperkinesia]

1 reference

12 December 2020

ON THE PATHOGENESIS OF HYPERCHOLESTEREMIC XANTHOMATOSIS

1 reference

12 December 2020

[Effects of tranquilizing drugs (reserpine, chlorpromazine) on extrapyramidal motility disorders]

1 reference

12 December 2020

EXCRETION OF DOPAMINE, CATECHOLAMINE METABOLITES AND 5-HYDROXYINDOLEACETIC ACID IN HEPATOLENTICULAR DEGENERATION (WILSON'S DISEASE)

1 reference

12 December 2020

Dihydroxyphenylalanine in extrapyramidal disease.

1 reference

12 December 2020

1 reference

12 December 2020

Identifiers

1 reference

11 August 2017

1 reference